Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Reported value range
Not reported

Koenig Sheldon L. President And CEO

Transaction date Jul 13, 2026
Public filing date Jul 13, 2026
Filing lag Filed same day

ESPR daily price context

Close on/before transaction
$3.2 Jul 13, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option (right to buy) on Common Stock
Quantity / price
642,000 shares
SEC ownership
Direct
Transaction code
D
Form
4
Filing identifier
0001628280-26-047999
Filing cohort

Transactions in this filing

Showing 4 of 4
Trades
4
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Esperion Therapeutics, Inc. ESPR Disposition Jul 13, 2026 Not reported
Esperion Therapeutics, Inc. ESPR Current Disposition Jul 13, 2026 Not reported
Esperion Therapeutics, Inc. ESPR Disposition Jul 13, 2026 Not reported
Esperion Therapeutics, Inc. ESPR Disposition Jul 13, 2026 Not reported